BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 16822850)

  • 1. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
    Zhong X; Pittman RN
    Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
    Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
    J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
    Laço MN; Cortes L; Travis SM; Paulson HL; Rego AC
    PLoS One; 2012; 7(9):e43563. PubMed ID: 22970133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different p97/VCP complexes function in retrotranslocation step of mammalian ER-associated degradation (ERAD).
    Ballar P; Pabuccuoglu A; Kose FA
    Int J Biochem Cell Biol; 2011 Apr; 43(4):613-21. PubMed ID: 21199683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
    Ballar P; Shen Y; Yang H; Fang S
    J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p97-dependent protein degradation by Eeyarestatin I.
    Wang Q; Li L; Ye Y
    J Biol Chem; 2008 Mar; 283(12):7445-54. PubMed ID: 18199748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
    Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
    J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates.
    Nowis D; McConnell E; Wójcik C
    Exp Cell Res; 2006 Sep; 312(15):2921-32. PubMed ID: 16822501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ER-associated degradation via p97/VCP-interacting motif.
    Ballar P; Fang S
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of p97-associated deubiquitinases in protein quality control at the endoplasmic reticulum.
    Liu Y; Ye Y
    Curr Protein Pept Sci; 2012 Aug; 13(5):436-46. PubMed ID: 22812527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.
    Fujita K; Nakamura Y; Oka T; Ito H; Tamura T; Tagawa K; Sasabe T; Katsuta A; Motoki K; Shiwaku H; Sone M; Yoshida C; Katsuno M; Eishi Y; Murata M; Taylor JP; Wanker EE; Kono K; Tashiro S; Sobue G; La Spada AR; Okazawa H
    Nat Commun; 2013; 4():1816. PubMed ID: 23652004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
    Burnett B; Li F; Pittman RN
    Hum Mol Genet; 2003 Dec; 12(23):3195-205. PubMed ID: 14559776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
    Doss-Pepe EW; Stenroos ES; Johnson WG; Madura K
    Mol Cell Biol; 2003 Sep; 23(18):6469-83. PubMed ID: 12944474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.
    Burnett BG; Pittman RN
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4330-5. PubMed ID: 15767577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3.
    Wang Q; Li L; Ye Y
    J Cell Biol; 2006 Sep; 174(7):963-71. PubMed ID: 17000876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: roles of endoplamic reticulum-bound p97/Cdc48p and proteasome.
    Elkabetz Y; Shapira I; Rabinovich E; Bar-Nun S
    J Biol Chem; 2004 Feb; 279(6):3980-9. PubMed ID: 14607830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
    Wang Y; Wan B; Zhou J; Li R; Yu L
    Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis.
    Boeddrich A; Gaumer S; Haacke A; Tzvetkov N; Albrecht M; Evert BO; Müller EC; Lurz R; Breuer P; Schugardt N; Plassmann S; Xu K; Warrick JM; Suopanki J; Wüllner U; Frank R; Hartl UF; Bonini NM; Wanker EE
    EMBO J; 2006 Apr; 25(7):1547-58. PubMed ID: 16525503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.